Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow

<p>Leukemia, Published online: 07 January 2026; <a href="https://www.nature.com/articles/s41375-025-02853-7">doi:10.1038/s41375-025-02853-7</a></p>Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrow